Tick tick tickets?
Is anyone selling their ticket?
I arrive to the Bay this week and would really like to experience the festival!
Also, I’ll be going solo if anyone would like to connect! 32 (M)
Cheers!
Is anyone selling their ticket?
I arrive to the Bay this week and would really like to experience the festival!
Also, I’ll be going solo if anyone would like to connect! 32 (M)
Cheers!
DRTS has been putting out a pretty strong stream of positive developments lately, which is why a lot of biotech traders are starting to pay attention again.
The biggest recent catalyst was the interim data from the company’s recurrent glioblastoma (brain cancer) trial. The first 3 patients treated showed:
100% local disease control
67% complete response rate
Favorable safety profile with no unresolved major safety issues
That’s a big deal because glioblastoma is one of the deadliest cancers with very limited treatment options. The market reacted strongly and the stock surged after the announcement.
The company has also been reporting strong pancreatic cancer data. In multiple Alpha DaRT pancreatic studies, DRTS reported:
100% local disease control in evaluable patients
Favorable safety results
Expanded FDA approval to increase the size of the IMPACT pancreatic trial from 30 to 40 patients
The company is now presenting this data at major oncology conferences like DDW and ASCO, which increases visibility with institutional investors and pharma partners.
Another bullish development is that DRTS completed enrollment for its pivotal ReSTART skin cancer trial, which is one of the company’s clearest paths toward FDA approval. Management has already begun parts of the PMA submission process.
Upcoming Catalyst Timeline
May–June 2026
Additional GBM follow-up data
ASCO presentations for pancreatic cancer
Head & neck cancer conference presentations
Continued momentum from recent interim trial results
Summer 2026
More pancreatic trial updates
Potential additional patient data from REGAIN GBM study
Ongoing international expansion of pancreatic trials
Late 2026
Initial pancreatic IMPACT trial readouts expected
More mature glioblastoma data
Possible Japan regulatory decisions
Potential FDA-related updates for ReSTART skin cancer program
End of 2026 / Early 2027
Potential completion of modular PMA submission to FDA
Commercial manufacturing scale-up milestones
Broader regulatory discussions if data remains strong
Overall, the bullish thesis is that DRTS has:
multiple active cancer trials
strong early efficacy signals
increasing FDA/regulatory momentum
upcoming catalysts almost every quarter
But it’s still a small-cap biotech, so volatility is going to be very high and future data will ultimately determine whether this becomes a major oncology story or not
Just booked my flights from US to Manila. What is the best airline to go from Manila to Siargao? I tried booking with Cebu Pacific, but their website kept crashing on me, so I’m wondering if there are other options.
I will be on a solo trip to surf and am very excited! Mainly to surf and DJ
Feel free to connect w me on I G
@ceejmanansala
I just spent a week and a half in NYC and had an amazing time.
I went on this trip to 1) visit my brother who recently moved there and 2) consider if I could see myself living there.
I’m 32 (M) and work in technical consulting for federal projects. After being in Hawaii for 13 years, I believe I could use a change of scenery. I’m single and hopefully have a better chance of meeting someone their that aligns with my
lifestyle/goals.
I’m curious how much of a demand there is for someone in my line of work over there.
In regards to groceries, I typically get bulk Costco deliveries shipped to my appt and wonder if that option exists over there.
I’m also curious how the rental market compares. I pay $3K for a relatively new appt in Hawaii, about 600 SF.
Eventually I want to start a family and I know it’d be difficult in NYC.
Lots to think about.
Anyone move there recently and can share how it’s going?
Anyone that’s been living there for a while have any considerations?
Thanks!